15.80Open15.80Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover0.00%IV-16.50%PremiumDec 20, 2024Expiry Date18.52Intrinsic Value100Multiplier27DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.90Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet